Medications for Anemia

24 results

  • azacitidine

    (AZACITIDINE)
    Eugia US LLC
    Azacitidine for injection is indicated for treating adult patients with specific myelodysplastic syndrome subtypes, including refractory anemia, refractory anemia with ringed sideroblasts (with complications), refractory anemia with excess blasts, and chronic myelomonocytic leukemia. Pediatric use is not labeled due to marketing exclusivity.

  • azacitidine

    (Azacitidine)
    Cipla USA Inc.
    Azacitidine for injection is indicated for adult patients with myelodysplastic syndromes (MDS), specifically subtypes such as refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, and chronic myelomonocytic leukemia.

  • bioferr 90

    (Dual-Iron)
    Biocon Pharma Inc.
    BioFerr™ 90 is indicated for treating all anemias responsive to oral iron therapy, including hypochromic anemia related to pregnancy, blood loss (acute or chronic), metabolic diseases, post-surgical recovery, and dietary deficiencies.

  • cerezyme

    (IMIGLUCERASE)
    Genzyme Corporation
    Cerezyme is indicated for the treatment of adults and pediatric patients aged 2 and older with Type 1 Gaucher disease associated with anemia, thrombocytopenia, bone disease, hepatomegaly, or splenomegaly.

  • desferal

    (deferoxamine mesylate)
    Novartis Pharmaceuticals Corporation
    DESFERAL is indicated for treating acute iron intoxication and for managing chronic iron overload in patients with chronic anemia. It is not suitable for primary hemochromatosis, where phlebotomy is preferred.

  • dexamethasone sodium phosphate

    (Dexamethasone Sodium Phosphate)
    A-S Medication Solutions
    This drug is indicated for various conditions, including endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders (e.g., rheumatoid arthritis), dermatologic diseases (e.g., severe psoriasis), allergic conditions, and certain hematologic and gastrointestinal diseases. It can be administered via intravenous, intramuscular, intra-articular, or intralesional injection.

  • dexamethasone sodium phosphate

    (Dexamethasone Sodium Phosphate)
    Henry Schein, Inc.
    This drug is indicated for various conditions such as endocrine disorders (e.g., adrenal insufficiency), rheumatic disorders (e.g., rheumatoid arthritis), allergic states, dermatologic diseases, gastrointestinal diseases, respiratory diseases, hematologic disorders, neoplastic diseases, and cerebral edema. It can be administered via injection or intra-articular methods.

  • ferriprox

    (deferiprone)
    Chiesi USA, Inc.
    FERRIPROX Tablets are indicated for treating transfusional iron overload in adults and pediatric patients (8 years and older) with thalassemia syndromes, sickle cell disease, or other anemias. Safety and effectiveness are not established for use in myelodysplastic syndrome or Diamond Blackfan anemia.

  • folcyteine

    (Multivitamin)
    PureTek Corporation
    Folcyteine™ is indicated as a vitamin supplement for men and women. It effectively treats megaloblastic anemias caused by folic acid deficiency, as well as anemias of nutritional origin in pregnancy, infancy, and childhood.

  • hematogen

    (FERROUS FUMARATE, ASCORBIC ACID, INTRINSIC FACTOR , CYANOCOBALAMIN)
    Nnodum Pharmaceuticals
    This drug is indicated for treating all anemias responsive to oral iron therapy, including hypochromic anemia due to pregnancy, blood loss, dietary restrictions, metabolic diseases, and recovery after surgery.